María Esteve

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean‐François Rahier, Fernando Magro, Cândida Abreu et al. · Journal of Crohn s and Colitis · 2014 · 921 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 642 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial

Pere Ginès, Antoni Rimola, Ramón Planas et al. · Hepatology · 1990 · 636 citations

Medicine, Microbiology, Pharmacology +13

Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis

María Esteve · Gut · 2004 · 467 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Torsten Kucharzik, Pierre Ellul, Thomas Greuter et al. · Journal of Crohn s and Colitis · 2021 · 452 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14